Greenleaf Trust’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.12M | Buy |
4,753
+11
| +0.2% | +$5.13K | 0.02% | 194 |
|
|
2025
Q4 | $2.15M | Buy |
4,742
+39
| +0.8% | +$16.8K | 0.02% | 192 |
|
|
2025
Q3 | $1.84M | Sell |
4,703
-334
| -7% | -$140K | 0.02% | 217 |
|
|
2025
Q2 | $2.24M | Sell |
5,037
-729
| -13% | -$336K | 0.02% | 179 |
|
|
2025
Q1 | $2.8M | Buy |
5,766
+272
| +5% | +$127K | 0.03% | 155 |
|
|
2024
Q4 | $2.21M | Buy |
5,494
+79
| +1% | +$36.6K | 0.02% | 181 |
|
|
2024
Q3 | $2.52M | Buy |
5,415
+19
| +0.4% | +$9.13K | 0.02% | 162 |
|
|
2024
Q2 | $2.53M | Buy |
5,396
+426
| +9% | +$185K | 0.02% | 153 |
|
|
2024
Q1 | $2.08M | Sell |
4,970
-7
| -0.1% | -$2.96K | 0.02% | 176 |
|
|
2023
Q4 | $2.03M | Buy |
4,977
+67
| +1% | +$24.8K | 0.02% | 176 |
|
|
2023
Q3 | $1.71M | Buy |
4,910
+166
| +3% | +$58.1K | 0.02% | 178 |
|
|
2023
Q2 | $1.67M | Sell |
4,744
-255
| -5% | -$85.9K | 0.02% | 185 |
|
|
2023
Q1 | $1.58M | Buy |
4,999
+7
| +0.1% | +$2.1K | 0.02% | 200 |
|
|
2022
Q4 | $1.44M | Buy |
4,992
+362
| +8% | +$110K | 0.02% | 202 |
|
|
2022
Q3 | $1.34M | Sell |
4,630
-30
| -0.6% | -$8.63K | 0.02% | 196 |
|
|
2022
Q2 | $1.31M | Buy |
4,660
+296
| +7% | +$79.2K | 0.02% | 185 |
|
|
2022
Q1 | $1.14M | Buy |
4,364
+667
| +18% | +$158K | 0.01% | 226 |
|
|
2021
Q4 | $812K | Buy |
3,697
+1,607
| +77% | +$312K | 0.01% | 297 |
|
|
2021
Q3 | $379K | Sell |
2,090
-1,061
| -34% | -$207K | ﹤0.01% | 499 |
|
|
2021
Q2 | $635K | Sell |
3,151
-316
| -9% | -$66.1K | 0.01% | 335 |
|
|
2021
Q1 | $745K | Buy |
3,467
+355
| +11% | +$78K | 0.01% | 271 |
|
|
2020
Q4 | $735K | Buy |
3,112
+214
| +7% | +$49.1K | 0.01% | 244 |
|
|
2020
Q3 | $789K | Sell |
2,898
-115
| -4% | -$31.7K | 0.01% | 205 |
|
|
2020
Q2 | $875K | Buy |
3,013
+388
| +15% | +$105K | 0.02% | 174 |
|
|
2020
Q1 | $625K | Buy |
2,625
+306
| +13% | +$70.2K | 0.01% | 189 |
|
|
2019
Q4 | $508K | Hold |
2,319
| – | – | 0.01% | 288 |
|
|
2019
Q3 | $393K | Buy |
2,319
+218
| +10% | +$38.6K | 0.01% | 337 |
|
|
2019
Q2 | $385K | Sell |
2,101
-42
| -2% | -$7.34K | 0.01% | 344 |
|
|
2019
Q1 | $394K | Buy |
2,143
+335
| +19% | +$61.9K | 0.01% | 315 |
|
|
2018
Q4 | $300K | Buy |
1,808
+140
| +8% | +$24.3K | 0.01% | 367 |
|
|
2018
Q3 | $321K | Buy |
1,668
+216
| +15% | +$38.5K | 0.01% | 375 |
|
|
2018
Q2 | $247K | Buy |
+1,452
| New | +$225K | ﹤0.01% | 426 |
|
|
2018
Q1 | – | Sell |
-152
| Closed | -$23K | – | 663 |
|
|
2017
Q4 | $23K | Sell |
152
-30
| -16% | -$4.44K | ﹤0.01% | 574 |
|
|
2017
Q3 | $28K | Buy |
+182
| New | +$27.4K | ﹤0.01% | 515 |
|
Other funds holding VRTX
VCM
VPM
Greenleaf Trust's VRTX Position: Q1 2026 in Review
Greenleaf Trust increased its Vertex Pharmaceuticals (VRTX) stake by 0.23% in Q1 2026, buying an estimated $5.13K and bringing the position to 4,753 shares worth $2.12M. The position accounts for 0.02% of the portfolio, ranked #194.
Greenleaf Trust first reported a position in VRTX in Q3 2017 and has held it in 34 quarters since. The position peaked at $2.8M in Q1 2025. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.
- Greenleaf Trust held 4,753 shares of Vertex Pharmaceuticals worth $2.12M as of Q1 2026.
- Greenleaf Trust bought 11 Vertex Pharmaceuticals shares in Q1 2026, an estimated $5.13K.
- Vertex Pharmaceuticals made up 0.02% of Greenleaf Trust's portfolio in Q1 2026, its #194 holding.
- Greenleaf Trust first reported a position in Vertex Pharmaceuticals in Q3 2017 and has held it in 34 quarters since.
- Greenleaf Trust's Vertex Pharmaceuticals position peaked at $2.8M in Q1 2025.
- 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.
Based on Greenleaf Trust's 13F filing for Q1 2026, filed 27 Apr 2026.